Nymox Update
July 13, 2023 10:16 ET
|
Nymox Pharmaceutical Corporation
IRVINE, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation [OTC Markets – NYMXF] (the “Company”) is providing additional information concerning recent changes in the...
Nymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of Nymox
July 12, 2023 09:30 ET
|
Nymox Pharmaceutical Corporation
IRVINE, Calif., July 12, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation [OTC Markets – NYMXF] (the “Company”) is pleased to announce the appointment of Patrick Doody as Nymox Vice...
NYMOX Update
July 07, 2023 17:02 ET
|
Nymox Pharmaceutical Corporation
IRVINE, Calif., July 07, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation [OTC Markets – NYMXF] (the “Company”) is providing information to address requests it has received for further...
Nymox Delisting from NASDAQ
July 05, 2023 18:11 ET
|
Nymox Pharmaceutical Corporation
IRVINE, Calif., July 05, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) today received a Nasdaq Hearing Delist Decision, noting that Nymox has not regained...
Nymox Provides Current Update
May 10, 2023 10:00 ET
|
Nymox Pharmaceutical Corporation
IRVINE, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to provide a mid-2nd quarter update on ongoing activities. The Company...
Nymox Provides Corporate Update
April 03, 2023 09:30 ET
|
Nymox Pharmaceutical Corporation
IRVINE, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to provide a current update on the Company's ongoing projects. The...
Nymox Announces Appointment of Christopher R. Riley as Chief Financial Officer
March 21, 2023 10:00 ET
|
Nymox Pharmaceutical Corporation
IRVINE, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce the appointment of Christopher R. Riley as Chief Financial...
Nymox Officially Granted Extension to Regain Listing Requirements
March 15, 2023 09:30 ET
|
Nymox Pharmaceutical Corporation
IRVINE, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) has officially been granted by NASDAQ an additional period until July 3, 2023 to...
Nymox Announces NYMOZARFEX Marketing Application is Accepted For Review
February 15, 2023 11:50 ET
|
Nymox Pharmaceutical Corporation
IRVINE, Calif., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that the Company's recent submission of Fexapotide Triflutate...
NYMOX Appeals Deficiency Letter
January 06, 2023 16:30 ET
|
Nymox Pharmaceutical Corporation
IRVINE, Calif., Jan. 06, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) reports that on January 4, 2023 the Company received a deficiency letter from The...